
@ColumbiaMSPH // Previously @ASCO clinical practice guidelines
Joined May 2022
- Tweets74
- Following55
- Followers27
- Likes137
Rachel Geisel retweeted
One of the most moving slides I’ve seen at an oncology conference👇🏻
I’ve often found survival curves to be sobering & dispassionate in equal measure, each declivity a nameless loss
But even when we have a 0% success rate at rendering patients immortal this is what they live FOR
Rachel Geisel retweeted
A cancer #drugshortage "is not a problem that will fix itself through the power of the markets,” explains ASCO member @Lymphoma_Doc.
Sign our Open Letter urging policymakers to act now to find solutions that will end this crisis: brnw.ch/21wJd5z #ASCOAdvocacy
Rachel Geisel retweeted
Our members are sending a clear message to policymakers: cancer #drugshortages have gone on for too long, and we need solutions now.
Add your voice and sign our Open Letter: brnw.ch/21wITOO #ASCOAdvocacy
Rachel Geisel retweeted
New resource-stratified guideline on systemic treatment of patients with metastatic #BreastCancer ➡️ brnw.ch/21wG1VH #bcsm #mBC
Rachel Geisel retweeted
This week we’re calling attention to the continued #drugshortage crisis and working to inform policymakers of the deeply distressing circumstance patients are facing.
Learn more and tell Congress to act now: brnw.ch/21wF0ok #ASCOAdvocacy #OncTwitter
Rachel Geisel retweeted
Drug Shortages in Oncology: @ASCO Clinical Guidance for Alternative Treatments @JCOOP_ASCO @OncoAlert @JCO_ASCO @jrgralow @CliffordHudis Unfortunately, it is still real and we need to be vigilant about how continue to optimize treatment for our patients ascopubs.org/doi/10.1200/OP.…
Great collaborating with @EdgardoSantosMD, @CathyEngMD, @amandanfader, Tom Oliver, Christina Lacchetti & Lalan Wilfong to produce guidance on treating pts during antineoplastic drug shortages for @JCOOP_ASCO. 15 chemo drugs currently in shortage.
ascopubs.org/doi/full/10.120…
Rachel Geisel retweeted
🚨 Check out what’s popular this week in #JCO:
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: @ASCO Guideline Update ➡️ fal.cn/3AhrC @WilliamDale_MD @rochgerionc @crisbergerot @VanitaNoronha #gerionc
Rachel Geisel retweeted
‼️ New clinical guidance available for #NSCLC during the current #drugshortages #lcsm
Bookmark asco.org/drug-shortages for the latest guidance and updates on the availability of cisplatin and carboplatin.
Rachel Geisel retweeted
‼️ New clinical guidance available for #mesothelioma during the current #drugshortages.
Bookmark asco.org/drug-shortages for the latest guidance and updates on the availability of cisplatin and carboplatin
Rachel Geisel retweeted
Thank u @JacqEHoward & @CNN for focusing on how the chemo shortage will impact current-and potentially future—patients. Clinical trials are being impacted at many cancer centers. @SGO_org & @ASCO continuing our efforts to help patients & work with Congress & @US_FDA on solutions.
This Post is from an account that no longer exists. Learn more
Rachel Geisel retweeted
#DrugShortages update for CARBOplatin:
Ingenus Pharmaceuticals now has 450 mg/45mL (10 mg/mL) available. For more information contact Ingenus team at 866-321-5031.
Rachel Geisel retweeted
A new @ASCO study, co-led by the HICCC's Dr. Dawn Hershman (@DrDawnHershman) has been awarded $11 million in research funding by @PCORI to study dosing strategies of oral CDK4/6 inhibitors in older adults living with metastatic breast cancer. @ColumbiaMed
old-prod.asco.org/about-asco…
Rachel Geisel retweeted
Now available: guideline update on practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: fal.cn/3zYJ1 #GeriOnc #SuppOnc
Rachel Geisel retweeted
🎙️Podcast🎙️ Listen in as we discuss the updated #GeriatricAssessment #Guidelines and the new Practical #GeriatricAssessment from @ASCO with @WilliamDale_MD @rochgerionc @HKlepinMD @BrittanyEHarvey sites.libsyn.com/115284/asco… #PracticalGA23 #OncoAlert #GeriOnc #OlderAdults #Cancer
Rachel Geisel retweeted
We’re accepting comments on our draft guideline, "Systemic Therapy in Men with Metastatic Castration-Resistant #ProstateCancer." Submit feedback to us by July 31: fal.cn/3zXtQ #pcsm
Rachel Geisel retweeted
❗❗ Read our clinical guidance for #ovarian cancer #germcell tumors during the current #drugshortages.
Bookmark asco.org/drug-shortages for the latest guidance and updates on the availability of cisplatin and carboplatin #gyncsm
Rachel Geisel retweeted
#DrugShortages Update for Cisplatin:
⚠️ Apotex/Qilu has 10 batches available. Call: 800-706-5575
⚠️ FDA-approved manufacturer, Gland Pharma Limited, will have a new supply starting the 3rd week of July, from their distributor, Sagent. Call: 866-625-1618
Rachel Geisel retweeted
Cancer #drugshortage ongoing crisis in the U.S. Platinum chemo critical to maintain high cure rate for #germcelltumors. See asco.org/drug-shortages for continued guidance from @ASCO, most recently updated to include #testiscancer (joining bladder, breast, GI, Gyn, H&N, SCLC...)























